Switch to ADA Accessible Theme
Close Menu
Baltimore Medical Malpractice & Birth Injury Attorneys / Blog / Cancer Misdiagnosis / False-Negative Biopsy Results: When an Incorrect Cancer Diagnosis Leads to Preventable Harm

False-Negative Biopsy Results: When an Incorrect Cancer Diagnosis Leads to Preventable Harm

__Misdiagnosis

Receiving a negative biopsy result can bring tremendous relief after weeks of uncertainty about a suspicious lump, abnormal imaging, or unexplained symptoms. Patients may return to their daily routines believing that cancer has been ruled out, only to discover months later that the disease was present all along. By then, the cancer may have progressed, requiring more aggressive treatment or limiting the options that were previously available.

An incorrect biopsy result can be particularly devastating when earlier warning signs suggested the need for further testing. Patients often depend on their physicians to interpret the findings and recognize when a reassuring pathology report does not match the broader clinical picture.

Determining how a malignancy went undetected may involve examining the original tissue sample, pathology findings, and subsequent medical decisions. Early legal guidance from an experienced Baltimore cancer misdiagnosis lawyer can help identify potential diagnostic failures and assess whether those failures contributed to a delay in treatment.

How False-Negative Biopsy Results Occur

A biopsy involves removing cells or tissue from a suspicious area for examination under a microscope. Pathologists evaluate the specimen for abnormal or cancerous cells, helping treating physicians determine whether further testing or treatment is necessary.

A false-negative biopsy occurs when cancer is present, but the tissue examination fails to detect it. One possible cause is a sampling error, where the collected specimen does not contain the malignant cells needed for an accurate diagnosis. Tumors may contain both cancerous and noncancerous tissue, making the location of the sample especially significant.

A needle biopsy that misses the malignant portion of a suspicious mass may produce a benign result despite the presence of cancer elsewhere in the lesion. Mistakes during specimen labeling, tissue preparation, or microscopic interpretation can also affect the accuracy of pathology findings and subsequent treatment decisions.

Missed Warning Signs After a Negative Biopsy

A negative pathology report does not always resolve concerns raised by imaging studies, physical examinations, or persistent symptoms. Physicians must consider whether the biopsy findings are consistent with the other available medical evidence.

In breast cancer evaluations, a suspicious mammogram or ultrasound may reveal a mass that appears concerning despite a benign tissue sample. This discrepancy, known as radiologic-pathologic discordance, may indicate that the biopsy failed to capture the abnormal tissue. Depending on the findings, additional imaging, repeat biopsy, or surgical removal of the suspicious lesion may be necessary.

Persistent lumps, unexplained bleeding, enlarging masses, or worsening symptoms may also warrant further evaluation. Relying on a single negative result despite continuing evidence of possible malignancy can delay the identification of cancer.

The Consequences of a Delayed Cancer Diagnosis

Cancer treatment depends on the disease’s type, location, and stage at diagnosis. Some cancers are more effectively treated before they invade surrounding tissues or spread to distant organs, although the rate of progression varies considerably.

A tumor that might initially have been treated through localized surgery may later require chemotherapy, radiation, or more extensive procedures. Advanced disease can also affect treatment eligibility, expected outcomes, and the ability to maintain ordinary activities.

Learning that cancer was present despite an earlier negative biopsy can be emotionally devastating. Patients may face difficult questions about whether months of symptoms, additional procedures, or worsening health could have been avoided. Although not every diagnostic delay changes a patient’s prognosis, some delays can reduce treatment opportunities or allow a previously localized malignancy to advance.

Healthcare Responsibilities When Biopsy Findings Conflict

Accurate cancer diagnosis depends on coordination among physicians ordering tests, specialists collecting tissue samples, radiologists interpreting imaging, and pathologists examining specimens. Each professional contributes information that may affect the patient’s diagnosis and subsequent treatment.

A pathologist may identify limitations in the submitted tissue, while a radiologist may recognize that the pathology findings do not adequately explain a suspicious lesion. Treating physicians must consider these findings together rather than relying on an isolated report.

Communication failures can occur when pathology concerns are not conveyed to the ordering physician, follow-up recommendations are overlooked, or responsibility for arranging additional testing remains unclear. A patient may consequently receive reassurance about a benign result without knowing that further evaluation was recommended.

When abnormal findings remain unresolved, delays can continue even after the test results are available. A recommended follow-up appointment or repeat biopsy may never be scheduled, leaving a suspicious lesion without further examination.

When a False-Negative Biopsy May Constitute Medical Malpractice

Even a carefully performed biopsy may fail to detect cancer if the collected tissue does not contain malignant cells. Medical negligence becomes a concern when the sampling, interpretation, or follow-up falls below accepted professional standards, and the resulting delay causes harm.

An improperly collected specimen, misinterpretation of pathology slides, or failure to pursue additional testing despite suspicious findings may support allegations of negligent care. The circumstances surrounding the original examination and the information available to the healthcare providers influence whether accepted standards were followed.

Maryland medical malpractice claims generally require evidence establishing a departure from the applicable standard of care and an injury caused by that failure. Under Maryland Courts and Judicial Proceedings § 3-2A-04, such claims are ordinarily subject to certificate of qualified expert requirements, with statutory exceptions and procedural conditions.

The medical evidence must also support a connection between the diagnostic error and the patient’s subsequent harm. A missed malignancy may have serious consequences, but the effect of an earlier diagnosis depends on the cancer’s characteristics and likely progression.

Reviewing the Diagnostic History After a Missed Cancer Diagnosis

Original pathology slides, tissue collection records, and subsequent imaging studies may reveal why a suspicious lesion was initially reported as benign. Comparing the first biopsy with later findings can establish whether the original specimen adequately represented the abnormal tissue or whether malignant cells were overlooked.

An independent pathology review may identify discrepancies in the interpretation of tissue samples. Oncology specialists can also examine the cancer’s progression between the original biopsy and confirmed diagnosis, including whether earlier detection would likely have changed the treatment course.

Working with a Baltimore cancer misdiagnosis lawyer can help clarify discrepancies between the original pathology report and later findings, including whether the initial specimen was properly collected, interpreted, and communicated to the treating physician. These records may reveal where the diagnostic process failed and which healthcare providers were involved.

Speak With a Baltimore Cancer Misdiagnosis Lawyer About a False-Negative Biopsy

If you or someone you love received a negative biopsy result only to be diagnosed with cancer months later, the experience may have left painful questions about whether earlier treatment could have made a difference. A delayed diagnosis can bring substantial physical, emotional, and financial consequences, particularly when the disease has advanced.

D’Amore Personal Injury Law, LLC represents patients affected by negligent cancer diagnosis throughout Baltimore, Maryland, and surrounding communities. We recognize the uncertainty and distress that can follow the discovery of a missed malignancy. Contact D’Amore Personal Injury Law, LLC today to speak with an experienced Baltimore cancer misdiagnosis lawyer about the circumstances of your delayed diagnosis and how we can help you seek justice for the harm caused by negligent medical care.

Sources:

Free Case Evaluation Contact Us

If you or a loved one has been injured by someone else’s negligence, contact us immediately.

* Required

By submitting this form I acknowledge that contacting D’Amore Personal Injury Law, LLC., through this website does not create an attorney-client relationship, and any information I send is not protected by attorney-client privilege.

protected by reCAPTCHA Privacy - Terms
Baltimore, MD Office

145 W Ostend St, Suite 600
Baltimore, MD 21230

Local: 410-324-2000

Fax: 443-782-0700

Washington, D.C. Office

1200 G Street NW, 8th Floor
Washington, D.C. 20005

Local: 202-780-9000

Fax: 443-782-0700